🇺🇸 Rondomycin in United States

Rondomycin (metacycline) regulatory status in United States.

Marketing authorisations

FDA

  • Status: approved

FDA

  • Application: ANDA060641
  • Marketing authorisation holder: MEDPOINTE PHARM HLC
  • Local brand name: RONDOMYCIN
  • Indication: CAPSULE — ORAL
  • Status: approved

Read official source →

Rondomycin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in United States

Frequently asked questions

Is Rondomycin approved in United States?

Yes. FDA has authorised it; FDA has authorised it.

Who is the marketing authorisation holder for Rondomycin in United States?

Marketing authorisation holder not available in our data.